ijms-logo

Journal Browser

Journal Browser

Advances in Targeted Therapies and Immunometabolic Pathways in Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 8

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Veterans Affairs, Miami VA Healthcare System, Miami, FL 33125, USA
2. Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA
3. South Florida VA Foundation for Research and Education, Miami, FL 33125, USA
4. Department of Surgery, Division of Thoracic Surgery, University of Miami, Miami, FL 33136, USA
Interests: platinum-resistant lung cancer; cisplatin; carboplatin resistant

Special Issue Information

Dear Colleagues,

The intricate interplay between tumor metabolism and immune evasion has established a transformative frontier in cancer therapy. As traditional approaches are challenged by drug resistance and limited durability, emerging strategies integrating targeted therapies with immunomodulation offer new hope. This Special Issue highlights the converging evidence that metabolic reprogramming, characterized by altered metabolism, not only sustains malignant growth but also reshapes the tumor immune microenvironment. Recent studies demonstrate that therapies targeting oncogenic signaling pathways, such as MYC, KRAS, and PI3K, can enhance tumor antigenicity and T-cell infiltration when combined with immune checkpoint blockade. Moreover, efforts to convert “cold” tumors into “hot” ones through modulation of the tumor microenvironment or the activation of innate immune pathways have shown promise in augmenting immunotherapeutic efficacy. Cellular therapies, including CAR-T and engineered NK cells, are being redesigned to overcome metabolic suppression within solid tumors. Collectively, these advances underscore the necessity of integrative, metabolism-informed approaches to immunotherapy.

This Special Issue brings together novel mechanistic insights, preclinical models, and translational strategies that will inform the next generation of combination treatments aimed at overcoming resistance and improving patient outcomes across diverse malignancies.

Dr. Medhi Wangpaichitr
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunotherapy
  • targeted therapy
  • tumor metabolism pathway
  • tumor microenvironment
  • immune checkpoint blockade
  • immune evasion
  • glucose/amino acids/lipid metabolism

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop